mRNA-Engineered Dendritic Cells Show Promise for Detecting Aquaporin-4 Immune Responses in NMOSD
Researchers developed an mRNA-based assay using reprogrammed dendritic cells to detect autoreactive T cell responses targeting the water channel protein aquaporin-4 (AQP4) in patients with neuromyelitis optica spectrum disorder (NMOSD). The assay successfully identified a robust AQP4-specific T cell response in a clinically active, untreated patient, while distinguishing NMOSD patients from healthy controls. The findings lay groundwork for personalized, tolerance-inducing therapies that could selectively suppress the disease-driving immune response rather than broadly suppressing immunity.
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system in which immune tolerance to aquaporin-4 (AQP4), a water channel protein, is lost. Current treatments do not restore this tolerance or selectively target the autoreactive immune cells responsible. In this study, researchers generated recombinant mRNAs encoding human AQP4 and used them to transfect patients' own dendritic cells, which were then co-cultured with autologous T cells in a stimulation assay. The approach was tested in eight NMOSD patients and ten healthy controls, and detected a strong AQP4-specific T cell response in a patient with recent disease activity who was not on immunosuppressive therapy. The assay demonstrated the ability to identify clinically relevant autoreactive T cell responses and distinguish them from background immune activity. The authors argue these results establish feasibility for using mRNA-engineered dendritic cells both as a research tool to study NMOSD pathogenesis and as a potential platform for developing personalized tolerance-inducing therapies.
What's missing
The study tested only eight NMOSD patients and ten healthy controls, making the sample size very small and limiting statistical power. It is unclear whether the assay can reliably detect AQP4-specific T cell responses in patients on immunosuppressive therapy, which represents the majority of treated patients. The study does not address long-term reproducibility of the assay, nor does it demonstrate therapeutic efficacy of the mRNA-dendritic cell approach — only its diagnostic feasibility. The relationship between T cell responses detected by this assay and clinical disease severity or relapse risk remains to be established.
What different sources said
- bioRxivCenter
Aquaporin-4-Specific T Cell Responses in NMOSD Revealed by mRNA-Engineered Dendritic Cells
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.